IXHL
Incannex Healthcare·NASDAQ
--
--(--)
--
--(--)
IXHL fundamentals
During Q2 2026, Incannex Healthcare (IXHL) reported revenue of 0, a YoY change of -100.00%. Net income was -6.52M, a YoY change of -10.64%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | Q2,2026 | TTM |
|---|
Start Date | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | -- |
Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 12.00K -- | 74.00K -- | 12.00K -- | -- -- | -- -- | 0 -100.00% | 0 -100.00% | -- -- |
Sales and Services Revenue | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 12.00K -- | -- -- | 12.00K -- | 0 -- | 0 -100.00% | -- -- | 0 -100.00% | -- -- |
Operating Expenses | 3.64M -- | 3.65M -- | 4.19M -- | 4.89M -- | 7.98M +119.37% | 7.42M +103.10% | 9.76M +132.62% | 6.33M +29.35% | 5.02M -37.17% | 5.00M -32.53% | 7.53M -22.84% | 6.79M +7.36% | 7.00M +39.45% | 26.32M -- |
Selling, General and Administrative Expenses | 2.09M -- | 2.01M -- | 2.48M -- | 2.28M -- | 5.34M +155.74% | 4.14M +105.67% | 5.40M +117.45% | 3.43M +50.26% | 3.60M -32.61% | 2.27M -45.19% | 3.83M -29.11% | 5.67M +65.33% | 4.71M +30.90% | 16.48M -- |
General and Administrative Expenses | -- -- | -- -- | 8.01M -- | 2.28M -- | 5.34M -- | 4.14M -- | 5.40M -32.64% | 3.43M +50.26% | 3.60M -32.61% | 2.27M -45.19% | 3.83M -29.11% | 5.67M +65.33% | 4.71M +30.90% | 16.48M -- |
Research and Development Expenses | 1.55M -- | 1.64M -- | 37.06M -- | 2.61M -- | 2.64M +70.30% | 3.28M +99.94% | 4.36M -88.24% | 2.90M +11.04% | 1.41M -46.40% | 2.73M -16.54% | 3.70M -15.07% | 1.12M -61.33% | 2.28M +61.24% | 9.84M -- |
Other Operating Expenses | -- -- | -- -- | -35.35M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -3.64M -- | -3.65M -- | -4.19M -- | -4.89M -- | -7.98M -119.37% | -7.42M -103.10% | -9.74M -132.33% | -6.25M -27.84% | -5.00M +37.32% | -5.00M +32.53% | -7.53M +22.74% | -6.79M -8.63% | -7.00M -39.79% | -26.32M -- |
Non-Operating Income (Loss) | 721.00K -- | 80.00K -- | 20.00K -- | 4.17M -- | 2.74M +280.31% | 1.38M +1630.00% | 3.31M +16465.00% | 834.00K -79.98% | -890.00K -132.46% | 1.03M -25.22% | -24.07M -826.68% | 387.00K -53.60% | 474.00K +153.26% | -22.18M -- |
Income (Loss) from Affiliates | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 6.00K -- | 11.00K -- | -- -- |
Income (Loss) from Joint ventures | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 6.00K -- | 11.00K -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | -282.00K -- | 1.82M -- | -23.17M -- | -- -- | 0 +100.00% | -- -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -67.00K -- | -2.00K -- | -5.00K -- | -11.00K -- | -11.00K +83.58% | -5.00K -150.00% | -326.00K -6420.00% | 41.00K +472.73% | 1.00K +109.09% | -13.00K -160.00% | -24.00K +92.64% | 5.00K -- |
Other Non-Operating Income (Loss) | 666.00K -- | -83.00K -- | -1.00K -- | 4.10M -- | 2.73M +309.46% | 1.32M +1690.36% | 3.28M +328500.00% | 811.00K -80.21% | -139.00K -105.10% | -702.00K -153.18% | -910.00K -127.71% | 389.00K -52.03% | 482.00K +446.76% | -741.00K -- |
Net Interest Expense | -55.00K -- | -163.00K -- | -88.00K -- | -71.00K -- | -20.00K +63.64% | -75.00K +53.99% | -40.00K +54.55% | -28.00K +60.56% | 143.00K +815.00% | 128.00K +270.67% | -2.00K +95.00% | -5.00K +82.14% | -5.00K -103.50% | 116.00K -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | -- -- | 171.00K -- | 132.00K -- | 0 -- | -- -- | 0 -100.00% | -- -- |
Interest Income | 55.00K -- | 163.00K -- | 88.00K -- | 71.00K -- | 20.00K -63.64% | 75.00K -53.99% | 40.00K -54.55% | 28.00K -60.56% | 28.00K +40.00% | 4.00K -94.67% | 2.00K -95.00% | 5.00K -82.14% | 5.00K -82.14% | 16.00K -- |
Pretax Income From Continuing Operations | -2.92M -- | -3.57M -- | -4.17M -- | -726.00K -- | -5.24M -79.61% | -6.03M -68.89% | -6.43M -54.07% | -5.42M -646.56% | -5.89M -12.46% | -3.97M +34.21% | -31.60M -391.42% | -6.41M -18.21% | -6.52M -10.64% | -48.50M -- |
Income Tax Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 30.00K -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- |
Net Income | -2.92M -- | -3.57M -- | -4.17M -- | -726.00K -- | -5.24M -79.61% | -6.03M -68.89% | -6.46M -54.79% | -5.42M -646.56% | -5.89M -12.46% | -3.97M +34.21% | -31.60M -389.13% | -6.41M -18.21% | -6.52M -10.64% | -48.50M -- |
Net Income Attributable to Owners of the Company | -2.92M -- | -3.57M -- | -4.17M -- | -726.00K -- | -5.24M -79.61% | -6.03M -68.89% | -6.46M -54.79% | -5.42M -646.56% | -5.89M -12.46% | -3.97M +34.21% | -31.60M -389.13% | -6.41M -18.21% | -6.52M -10.64% | -48.50M -- |
Net Income Attributable to Common Stockholders | -2.92M -- | -3.57M -- | -4.17M -- | -726.00K -- | -5.24M -79.61% | -6.03M -68.89% | -6.46M -54.79% | -5.42M -646.56% | -5.89M -12.46% | -3.97M +34.21% | -31.60M -389.13% | -6.41M -18.21% | -6.52M -10.64% | -48.50M -- |
Other Comprehensive Income | 3.68M -- | -202.00K -- | -263.00K -- | -510.00K -- | 927.00K -74.84% | -820.00K -305.94% | 326.00K +223.95% | 339.00K +166.47% | -414.00K -144.66% | -88.00K +89.27% | 371.00K +13.80% | 223.00K -34.22% | -287.00K +30.68% | 219.00K -- |
Total Comprehensive Income | 766.00K -- | -3.77M -- | -4.44M -- | -1.24M -- | -4.31M -663.19% | -6.85M -81.58% | -6.13M -38.27% | -5.08M -311.08% | -6.31M -46.22% | -4.06M +40.80% | -31.23M -409.08% | -6.18M -21.71% | -6.81M -7.93% | -48.28M -- |
Total Comprehensive Income Attributable to Owners of the Company | 766.00K -- | -3.77M -- | -4.44M -- | -1.24M -- | -4.31M -663.19% | -6.85M -81.58% | -6.13M -38.27% | -5.08M -311.08% | -6.31M -46.22% | -4.06M +40.80% | -31.23M -409.08% | -6.18M -21.71% | -6.81M -7.93% | -48.28M -- |
Basic EPS | 0.05 -- | -0.22 -- | 0 -- | -0.08 -- | -0.33 -760.00% | -0.38 -72.73% | -0.37 -- | -0.29 -262.50% | -0.33 -- | -0.2 +47.37% | -0.16 +56.76% | -0.02 +93.10% | -0.02 +93.94% | -0.4 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -0.08 -- | -0.33 -- | -0.38 -- | -- -- | -0.29 -262.50% | -0.33 -- | -0.2 +47.37% | -- -- | -0.02 +93.10% | -0.02 +93.94% | -- -- |
Diluted EPS | 0.05 -- | -0.22 -- | -- -- | -0.08 -- | -0.33 -760.00% | -0.38 -72.73% | -- -- | -0.29 -262.50% | -0.33 -- | -0.2 +47.37% | -- -- | -0.02 +93.10% | -0.02 +93.94% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -0.08 -- | -0.33 -- | -0.38 -- | -- -- | -0.29 -262.50% | -0.33 -- | -0.2 +47.37% | -- -- | -0.02 +93.10% | -0.02 +93.94% | -- -- |
You can ask Aime
What does Incannex Healthcare do and what are its main business segments?What is the revenue and EPS growth rate for Incannex Healthcare year over year?What factors drove the changes in Incannex Healthcare's revenue and profit?What is the market's earnings forecast for Incannex Healthcare next quarter?What were the key takeaways from Incannex Healthcare's earnings call?Did Incannex Healthcare beat or miss consensus estimates last quarter?What is Incannex Healthcare's gross profit margin?What is Incannex Healthcare's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
